Marie-claude Geoffroy

Marie-Claude's undergraduate studies were carried out at the University of Pierre et Marie Curie in Paris before she obtained a Ph.D in virology from the University of Nantes (France) working with Philippe Moullier and Anna Salvetti. During her Ph.D, she studied the role of ICP0, a herpesvirus ubiquitin E3 ligase in reactivation of Adeno-Associated Virus gene expression. Marie-Claude joined the lab of Ron Hay in 2005 as a post-doctoral research assistant funded by the EU Network of Excellence on ubiquitin and ubiquitin-like proteins.

From/To : 2005-2010

Current position : Independent Investigator, INSERM/CNRS/University Paris, France

Neil Hattersley

Neil joined the Hay lab in Autumn 2005 having completed his BMedSc in Cell and Molecular Biology at the University of Birmingham. Neil studied for a PhD funded by the BBSRC investigating the role of the SUMO protease SenP6 in mitotic cell division.

From/To : 2007-2011

Current position : Postdoc with Arshad Desai, UCSD, San Diego, USA

Joy ShiJia Chua

Joy joined the Hay lab in September 2008 as a PhD student and is funded by A*STAR under the A*STAR-Dundee Partnership programme. She graduated with a BSc (Hons) in Biological Sciences at Nanyang Technological University in Singapore and worked for a year as a research officer in cancer biology at the Institute of Molecular and Cell Biology in Singapore before embarking on her postgraduate studies. She worked on the role of RNF4 in the DNA damage response.

From/To : 2009-2011

Current position : Postdoc with David Lane, Immunos, Singapore

Roland Bruderer

Roland obtained his PhD in the laboratory of Dr. H. H. Meyer at the Swiss Federal Institute of Technology ETH Zurich in 2008. His research topic was the regulation of Aurora B at the end of mitosis. The research was carried out in the cell free Xenopus laevis egg extract system. He joined the laboratory in March 2009 to establish methods for the sumo proteomics.

From/To : 2009-2011

Current position : Senior Scientist with Biognosys AG, Zurich, Switzerland

Filip Golebiowski

Filip first came to the lab in May 2002, during his days as a PhD student. After working as a post-doc in the USA (2003 – 2005) he returned to the lab on a Marie Curie research fellowship. Filip worked mostly on the role that SUMO proteins play in cellular function, especially as a part of complex protein networks.

From/To : 2006-2011

Current position : Technical support specialist, Quagen, Poland

Katherine Hands

Katie joined the lab in October 2009 to start a PhD funded by the Wellcome Trust in their PhD Programme for Clinicians, and was investigating the mechanism of degradation of PML by arsenic. She graduated in medicine in 2003 from the University of Dundee and have practised hospital based medicine since then. She is particularly interested in haemato-oncology. In the longer term she hopes to combine clinical medicine with ongoing laboratory research.

From/To : 2009-2012

Current position : Consultant Haematologist, Ninewells Hospital, Dundee.

Helena Salmen

In 2008 Helena graduated from the University of Heidelberg from where she obtained a BSc in Molecular Biotechnology. After that she joined the 4-year Wellcome Trust PhD programme at the University of Dundee. She spent her first year of the programme doing rotations in three different labs and finally joined Ron’s group for her PhD in 2009, to investigate the in vivo role of PML and the molecular specificity of the E2 ubiquitin conjugating enzyme Ube2W.

From/To : 2008-2012

Current position : Medical Information, Mundipharma, Limburg, Germany

Ivan Matic

Born in Croatia and brought up in Croatia and Italy, Ivan obtained his Master degree in Pharmaceutical Biotechnology from the University of Bologna. After a short visit in Ivan Dikic’s lab in Frankfurt, he joined Matthias Mann’s group at the Max Planck Institute of Biochemistry in Munich, where in 2009 he obtained his doctoral degree with the thesis title “Proteomics of SUMO, the small ubiquitin-like modifier”. As a Sir Henry Wellcome Postdoctoral Fellow, Ivan joined Ron Hay group to conduct his research at the interface of sumoylation, mass spectrometry-based proteomics and systems biology.

From/To :2010-2014

Current position : CECAD principal investigator, Max Planck Institute for Biology of Ageing, Cologne, Germany

John Bett

John carried out his undergraduate studies at Glasgow University where he gained a B.Sc. (Hons) in Genetics in 2002.  After a year working as a research assistant in the USA, he moved to London in 2003 to carry out his Ph.D. in Gill Bates’ lab investigating the role of the ubiquitin system in polyglutamine disease.  He then carried out postdoctoral work at University College London in Mike Cheetham’s lab (2007-2010) on the role of the ubiquitin-like modifier FAT10 in an inherited blindness.

John joined Ron Hay’s group in May 2010 where he’s worked on siRNA screening studies to identify components of the ubiquitin and ubiquitin-like modifier systems that are involved in specific human disease pathways.

From/To :2010-2014

Current position : Medical Writer at Chameleon Communications International
London, United Kingdom

Oliver Anderson

Ollie shares one important attribute with Ron Hay; he's a Dundonian. He joined the Lab as a PhD student in November 2012 after completing an undergraduate degree in Biochemistry at the University of Dundee the same year. For his final year Honours research project he helped to develop an ELISA assay capable of detecting and quantifying SUMO modified protein from cell extracts. His PhD project aimed to idntify proteins with both SUMO and ubiquitin interacting ability.

From/To: 2012-2015

Current position : Studying Dentistry at Glasgow University,

Anne Seifert

Anne joined the lab as a postdoctoral researcher in October 2008. She carried out her undergraduate studies at the University of Leipzig (Germany, 1999-2002) and the University of Manchester (2002-2004), from where she obtained a BSc in Cell Biology. She then joined the lab of Professor Paul Clarke at the University of Dundee to study for a PhD research focussed on the regulation of caspase-9.

From/To: 2008-2016

Current position : Medical Science Manager, Bristol-Myers Squibb, UK

Amit Garg

Amit carried out his Masters studies at University of Abertay Dundee where he gained M.Sc. in Bioinformatics in 2005.  After a year working as a project assistant in the Abertay Centre for Environment under Prof Kevan Gartland, he moved to Millipore in 2006 to handle high throughput screening data from kinase profiling .

Amit joined the siRNA Screening Team in SCILLS under Ron Hay in Dec 2008 where he handled the large volumes of siRNA screening data.

From/To :2008-2016

Current position : Senior Scientist at Sygnature Discovery, Nottingham, UK

Jean-François was born and educated in south Charente in-between Bordeaux and Cognac. He studied for his PhD in Dr. Jean-Paul Javerzat Lab at Bordeaux University establishing the role of constitutive heterochromatin for sister chromatid cohesion at centromeres.

Postdoctoral work allowed him to carry out the characterization of the role of Mps1 kinase and kinetochore components in sister-centromeres bi-orientation establishment in Dr. Tomoyuky Tanaka (Dundee University, 2004-2009).

He joined the lab in 2010, in order to identify the role of protein associated to Ubiquitin/ SUMO pathway in genome maintenance after DNA damage.

From/To: 2010-2016

Current position :

Alejandro's undergraduate studies were carried out at the University of Chile where he was working on iron homeostasis in the lab of Dr. Tulio Nunez. He then moved to the University of Constance in Germany where he gained a PhD in the laboratory of Dr. Martin Scheffner, supported by a Doctoral Fellowship from the German Academic Exchange Service (DAAD). His work was focussed on the regulation of Hdm2-mediated ubiquitination and neddylation of p53, as well as on characterizing the activity of the Nedd8 conjugating enzyme Ube2F/Nce2.

He joined the siRNA screening team at the Scottish Institute for Cell Signaling (SCILLS) in July 2010 under Ron Hay as a postdoctoral researcher with the goal of identifying components of the Ubiquitin and Ubiquitin-like modifier that are involved human disease.

From/to: 2010-2016

Current position : Principal Investigator, Espacio CISNE, Facultad de Medicina
Universidad Austral de Chile, Campus Isla Teja S/N, Valdivia, 511-0566, Chile

Peter came to the lab in 2014 to undertake proteomic characterisation of the PIAS family of SUMO E3 ligases

From/to: 2014-2016

Current position :

Triin started her PhD programme in 2012, becoming the first Estonian to join the lab. Prior to her arrival, she obtained her MSc in Molecular Biology from the University of Tartu, Estonia. She became interested in mass spectrometry-based proteomics during her MSc studies, when she also worked as a research specialist at the Proteomic core facility at the University of Tartu. During her PhD, Triin focused on method development for the identification of SUMO modification sites using mass spectrometry.

From/to: 2013-2017

Current position :

Updated 14/08/17